Surprise, Surprise: Pharma Abusing IP Laws To Prevent Competition
from the live-by-ip... dept
Thus it should come as no surprise at all that a new report has found that pharmaceutical companies are regularly abusing patents for anti-competitive purposes (thanks Rob Hyndman for the link):
Pharmaceutical companies are manipulating the intellectual property rights system and are "actively trying to delay the entry of generic medicines onto their markets," a top EU official said of an EU inquiry into the pharmaceutical sector released Wednesday. As a result, there has been a decline in the number of innovative medicines getting to the market, it says.In other words, contrary to the popular myth, patents are actually being used to hold back innovation in the healthcare market.